1.Naoum GE, Morkos M, Kim B, Arafat W. Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol Cancer. 2018;17:51. doi: 10.1186/s12943-018-0786-0
2. Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci. 2019;16:450-460. doi: 10.7150/ijms.29935
3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133. doi: 10.1089/thy.2015.0020
4. Vuong HG, Duong UN, Altibi AM, Ngo HT, Pham TQ, Tran HM, et al. . A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connect. 2017;6:R8-R17. doi: 10.1530/EC-17-0010
5. Brauner E, Gunda V, Vanden Borre P, Zurakowski D, Kim YS, Dennett KV, et al. . Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer. Oncotarget. 2016;7:17194-211. doi: 10.18632/oncotarget.7839
6. Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. . Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci. 2019;20:4413. doi: 10.3390/ijms20184413
7. Imam S, Dar P, Paparodis R, Almotah K, Al-Khudhair A, Hasan SA, et al. .Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer. J Immunother Cancer. 2019;7:3. doi: 10.1186/s40425-018-0483-y
8. Liyanarachchi S, Li W, Yan P, Bundschuh R, Brock P, Senter L, et al. . Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis. J Clin Endocrinol Metab. 2016;101:4005-4013. doi: 10.1210/jc.2016-1991
9. Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). 2017;49:588-597. doi: 10.1093/abbs/gmx047
10. Teng H, Mao F, Liang J, Xue M, Wei W, Li X, et al. . Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma. Theranostics. 2018;8:4345-4358. doi: 10.7150/thno.26862
11 Jiang MC, Ni JJ, Cui WY, Wang BY, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9:1354-1366.
12. Yu WD, Wang H, He QF, Xu Y, Wang XC. Long noncoding RNAs in cancer-immunity cycle. J Cell Physiol. 2018;233:6518-6523. doi: 10.1002/jcp.26568
13. Vishnubalaji R, Shaath H, Elkord E, Alajez NM. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling. Cell Death Discov. 2019;5:109. doi: 10.1038/s41420-019-0190-6
14. Wang Y, Song B, Zhu L, Zhang X. Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer. PeerJ. 2019;7:e7976. doi: 10.7717/peerj.7976
15. Sun Y, Ling C. Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer. Medicine (Baltimore). 2019;98:e16437. doi: 10.1097/MD.0000000000016437
16. Yang H, Yang W, Dai W, Ma Y, Zhang G. LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non-small cell lung cancer through stabilizing VEGFA by EIF4A3. Cell Biol Int. 2020;44:1671-1680. doi: 10.1002/cbin.11361
17. Zhou W, Liu T, Saren G, Liao L, Fang W, Zhao H. Comprehensive analysis of differentially expressed long non-coding RNAs in non-small cell lung cancer. Oncol Lett. 2019;18:1145-1156. doi: 10.3892/ol.2019.10414
18. Zhu M, Lv Q, Huang H, Sun C, Pang D, Wu J. Identification of a four-long non-coding RNA signature in predicting breast cancer survival. Oncol Lett. 2020;19:221-228. doi: 10.3892/ol.2019.11063
19. Chen Y, Bi F, An Y, Yang Q. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer. J Cell Biochem. 2019;120:14444-14454. doi: 10.1002/jcb.28704
20. Gu J, Zhang X, Miao R, Ma X, Xiang X, Fu Y, et al. . A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma. Aging (Albany NY). 2018;10:1627-1639. doi: 10.18632/aging.101497
21. Zhou M, Zhang Z, Bao S, Hou P, Yan C, Su J, et al. . Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer. Brief Bioinform. 2021;22:bbaa047. doi: 10.1093/bib/bbaa047
22. Nie Y, Jiao Y, Li Y, Li W. Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer. Biomed Res Int. 2019;2019:4602371. doi: 10.1155/2019/4602371
23. Wang W, Li J, Lin F, Guo J, Zhao J. Identification of N6-methyladenosine-related lncRNAs for patients with primary glioblastoma. Neurosurg Rev. 2021;44:463-470. doi: 10.1007/s10143-020-01238-x
24. Li Q, Wang P, Sun C, Wang C, Sun Y. Integrative Analysis of Methylation and Transcriptome Identified Epigenetically Regulated lncRNAs With Prognostic Relevance for Thyroid Cancer. Front Bioeng Biotechnol. 2020;7:439. doi: 10.3389/fbioe.2019.00439
25. Li X, Dai D, Wang H, Wu B, Wang R. Identification of prognostic signatures associated with long-term overall survival of thyroid cancer patients based on a competing endogenous RNA network. Genomics. 2020;112:1197-1207. doi: 10.1016/j.ygeno.2019.07.005
26. Wang H, Wu J, Guo W. SP1-Mediated Upregulation of lncRNA LINC01614 Functions a ceRNA for miR-383 to Facilitate Glioma Progression Through Regulation of ADAM12. Onco Targets Ther. 2020;13:4305-4318. doi: 10.2147/OTT.S242854
27. Sun Y, Ling C. Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer. Medicine (Baltimore). 2019;98:e16437. doi: 10.1097/MD.0000000000016437
28. Sui YX, Zhao DL, Yu Y, Wang LC. The Role, Function, and Mechanism of Long Intergenic Noncoding RNA1184 (linc01184) in Colorectal Cancer. Dis Markers. 2021;2021:8897906. doi: 10.1155/2021/8897906
29. Qiu X, Tian Y, Xu J, Jiang X, Liu Z, Qi X, et al. . Development and Validation of an Immune-Related Long Non-coding RNA Prognostic Model in Glioma. J Cancer. 2021;12:4264-4276. doi: 10.7150/jca.53831
30. Li Z, Lin W, Zheng J, Hong W, Zou J, Zhang T, et al. . Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer. Biosci Rep. 2021;41:BSR20204086. doi: 10.1042/BSR20204086